The central objectives for the next period of funding are: (1) to characterize the conformational changes induced in DNA by two DNA binding proteins, namely, the cro repressor of bacteriophage lambda and the histone-like HU protein of E. coli; (2) to further characterize the geometries of immobile, four-way DNA junctions; and (3) the characterization of the conformational properties of several common elements of non-helical structure found in RNA. The two protein-DNA interactions represent paradigms for the study of sequence-specific and non-specific interactions, respectively; such interactions will be studied from the standpoint of the alterations in helix axis direction which accompany complex formation. The study of four-way DNA junctions is designed to increase our understanding of the conformational properties of cruciforms as well as intermediates in site-specific and general recombination. With regard to the latter, we hope eventually to provide a mechanistic basis for the interactions of recombinases/resolvases with branched DNA structures. The study of intermediate-to-long-range RNA structure, the major emphasis of the proposed research, should provide a unique perspective on the overall three-dimensional structures of RNA molecules. We know of no other studies of the type proposed herein. Our methods of approach to all three objectives are similar: combined gel electrophoretic and birefringence decay studies will be used to define alterations in the directions of DNA or RNA helix axes, which arise from the structural element being studied (protein-DNA complex; junction; non-helical element). Gel electrophoresis provides qualitative information pertaining to axial distortions, as a consequence of reductions in electrophoretic mobility that accompany axial curvature. Birefringence decay measurements, when combined with computational analyses of hydrodynamic behavior, provide more quantitative information regarding axial bending.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM035305-06
Application #
3287805
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1985-09-10
Project End
1991-06-30
Budget Start
1990-09-01
Budget End
1991-06-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Mills, Janine B; Hagerman, Paul J (2004) Origin of the intrinsic rigidity of DNA. Nucleic Acids Res 32:4055-9
Frazer-Abel, Ashley A; Hagerman, Paul J (2004) Variation of the acceptor-anticodon interstem angles among mitochondrial and non-mitochondrial tRNAs. J Mol Biol 343:313-25
van Oppen, Madeleine J H; Catmull, Julian; McDonald, Brenda J et al. (2002) The mitochondrial genome of Acropora tenuis (Cnidaria; Scleractinia) contains a large group I intron and a candidate control region. J Mol Evol 55:1-13
Greco, C M; Hagerman, R J; Tassone, F et al. (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760-71
Tassone, F; Hagerman, R J; Taylor, A K et al. (2001) A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet 38:453-6
Stagg, S M; Frazer-Abel, A A; Hagerman, P J et al. (2001) Structural studies of the tRNA domain of tmRNA. J Mol Biol 309:727-35
Chiang, P W; Carpenter, L E; Hagerman, P J (2001) The 5'-untranslated region of the FMR1 message facilitates translation by internal ribosome entry. J Biol Chem 276:37916-21
Hagerman, P J (2000) Transient electric birefringence for determining global conformations of nonhelix elements and protein-induced bends in RNA. Methods Enzymol 317:440-53
Tassone, F; Hagerman, R J; Taylor, A K et al. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:15-Jun
Tassone, F; Hagerman, R J; Loesch, D Z et al. (2000) Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 94:232-6

Showing the most recent 10 out of 35 publications